1. Introduction {#sec1}
===============

The conduction velocity (CV) of action potentials along axons is a key neurophysiological property upon which neural communication depends. While *in vivo* CV measurements in peripheral nerves are comparatively trivial, it is currently not possible to obtain *in vivo* estimates of CV in the central nervous system (CNS). The ability to make such estimates, however, would yield a great deal of insight into how the brain encodes and integrates information and how such mechanisms are optimised in the human brain ([@bib60]; [@bib57]; [@bib17]; [@bib73]; [@bib13]; [@bib64]; [@bib32]; [@bib41]). Furthermore, being able to image CV in CNS axons *in vivo* would allow us to identify individual differences in CV, and examine how and why CV is altered in healthy development, ageing and disease states.

Previously, simple relationships between axon morphology and CV have been derived from early electrophysiological and theoretical literature ([@bib34]; [@bib38]; [@bib39]; [@bib63]; [@bib70]; [@bib83]; [@bib52]; [@bib75]) (see [@bib82] for a review). In particular, [@bib63] derived a very simple relationship: $v \propto Dg\sqrt{- \text{ln}\left( g \right)} \propto d\sqrt{- \text{ln}\left( g \right)}$, where *d* is the inner axon diameter, *D* is the outer fibre (axon plus myelin sheath) diameter and *g* is the ratio between the two, $g = d/D$. An alternative model derived by [@bib83] models CV as a simple linear function of outer fibre diameter: $v \propto D \propto d/g$. The constant of proportionality of this relationship usually falls in the range of 5.5--6.0 $\text{m}\ \text{s}^{- 1}/\text{μm}$ and is often used as a simple way of predicting CV from fibre diameter ([@bib15]; [@bib76]; [@bib43]).

Recent developments in MRI acquisition technology and modelling claim to provide non-invasive estimates of microstructural attributes relevant to CV, including axon diameter (AD) ([@bib8]; [@bib4]), axonal volume fractions (AVF) ([@bib7]; [@bib87]), myelin volume fractions (MVF) ([@bib25]; [@bib85]; [@bib28]; [@bib16]) and g-ratios ([@bib72]; [@bib21]). It is tempting, therefore, to speculate that one might use this information to obtain individual-specific estimates of CV *in vivo*. The literature is currently sparse regarding attempts to do this. [@bib37], showed a correlation between MRI-based estimates of AD and inter-hemispheric transfer delay measured with electroencephalography, implying MRI-derived estimates of AD correlate with CV. A more recent study is that of [@bib11]. Here, g-ratios were estimated in human corpus callosum from macromolecular tissue volume (MTV) estimates of myelin and diffusion based-estimates of axonal volume fraction. AD was not derived from the same subjects but extrapolated from existing histology data ([@bib1]). This approach showed slightly slower CVs in older subjects compared to slower subjects. However, the authors conclude that individual-specific estimates of AD would be essential for modelling individual-specific CV.

These studies assume simple relationships between axonal microstructural parameters and CV. However, beyond these parameters, CV depends, to a greater or lesser extent, on a number of parameters that are not currently accessible *in vivo*, and yet contribute considerable variability across fibre populations and across individuals. These include the distance between the nodes of Ranvier, inter-nodal spacing, and electrical properties of the axonal and myelin membranes. We address these issues through simulation and then present some CV estimates in human corpus callosum obtained from *in vivo* MRI data.

2. Sensitivity of CV to axonal parameters {#sec2}
=========================================

This section addresses the first issue: How sensitive is CV to axonal parameters and are the simplified models of CV sufficient to capture variance in CV when many other relevant parameters are inaccessible to *in vivo* MRI?

The physiological mechanisms of an axon\'s action potential propagation have a complex dependency on many parameters that cannot be quantified *in vivo*. In particular, microstructural properties of the nodes of Ranvier, including their length and diameter, contribute to the surface area on which permeable ion channels can reside, impacting on the electrical properties of the axon. Moreover, the inter-nodal distance is important in determining how many instances of depolarisation are required for an action potential to traverse a unit length of axon. Given these various factors, it is important to establish whether it is feasible to obtain accurate estimates of CV from a simplified model using only parameters that have previously been reported as being quantifiable using MRI.

A sensitivity analysis on parameters affecting CV has previously been performed ([@bib52]). However, this utilised a simple one-at-a-time (OAAT) analysis (where each parameter is varied one at a time) which does not consider *combinations* of parameters, and how interactions between parameter changes affect CV. Moreover, a number of important properties that affect the excitation of the axonal membrane, such as the peri-axonal space, were omitted in that previous analysis. Here, we perform a more comprehensive analysis. We perform extensive simulations of axon physiology using the model of [@bib61] and perform sensitivity analysis to determine the sensitivity of CV across a wide region of the parameter space, and to quantify the variance in CV accounted for by each parameter.

2.1. Method {#sec2.1}
-----------

### 2.1.1. Core electrophysiological simulations {#sec2.1.1}

The 'Model C' axon model of [@bib61], as implemented by [@bib6] (code obtained from <https://github.com/AttwellLab/MyelinatedAxonModel>) was used to analyse the sensitivity of CV to variance in each of the 14 parameters listed in the upper part of [Table 1](#tbl1){ref-type="table"}. Model parameters derived from optic nerve ([@bib6]; [@bib12]) were used as a proxy for CNS axons. Some parameters were assumed to be well-constrained across individuals and fibre populations and thus not tested (fixed parameters listed in [Table 1](#tbl1){ref-type="table"}). Others, such as the number of myelin wraps and myelin thickness, are dependent on g-ratio, AD and myelin periodicity, and so were not directly manipulated. The simulated axon was comprised of 50 laminated internodal regions. All parameters were kept constant across all nodes and internodes along the length of the axon. Some internode parameters, such as periaxonal width, were varied at the paranode to accommodate unique morphological characteristics in these regions (see [@bib51] for further details).Table 1Baseline and range values for each parameter tested for parameters of interest and values for fixed parameters of the Richardson model. All baseline values were those used in [@bib6]. values for ranges were obtained from \[1\] [@bib6] or \[2\] [@bib12] otherwise 20% of the baseline value was used.Table 1Varied parametersParameterUnitsBaseline value ($\phi_{i}$) \[1\]$\pm$ Limits ($\left| \text{Δ}\phi_{i} \right|$)Axon diameter$\text{μm}$0.820.31 \[1\]Node diameter$\text{μm}$0.730.19 \[2\]Node length$\text{μm}$1.020.15 \[1\]Internode length$\text{μm}$139.2631.53 \[1\]Peri-axonal widthnm153Myelin periodicitynm15.63.12g-ratio--0.780.057 \[2\]Internode leakage conductance$\text{mS}\text{cm}^{- 2}$0.10.02Intra-axonal resistivity$\text{Ω}\ \text{m}$0.70.14Peri-axonal resistivity$\text{Ω}\ \text{m}$0.70.14Myelin conductance$\text{mS}\text{cm}^{- 2}$10.2Fast Na ​+ ​conductance$\text{mS}\text{cm}^{- 2}$306Persistent Na ​+ ​conductance$\text{mS}\text{cm}^{- 2}$0.050.01Slow K+ conductance$\text{mS}\text{cm}^{- 2}$0.80.16**Parameters dependent on varied parameters**ParameterUnitsBaseline valueMyelin width$\text{μm}$0.101Myelin periodicitynm15.6\# of myelin wraps--7Node diameter$\text{μm}$0.73Internode diameter$\text{μm}$1.05Paranode diameter$\text{μm}$1.02Paranode length$\text{μm}$2.11Periaxonal width at internodenm15Effective periaxonal width at paranodenm0.0077**Fixed parameters**Temperature$$37Number of nodes--50Stimulus amplitude (baseline condition)nA2.73Stimulus durationms10Axon capacitance$\text{μF}\text{cm}^{- 2}$0.9Node capacitance$\text{μF}\text{cm}^{- 2}$0.9Myelin membrane capacitance$\text{μF}\text{cm}^{- 2}$0.9Node Resting potentialmV−82Node Reversal potentialmV−83.4Na ​+ ​reversal potentialmV50K+ reversal potentialmV−84Table 2Goodness of fit statistics for candidate simplified models to data generated from the Richardson model.Table 2ModelSSE$R^{2}$Adj. $R^{2}$RMSE*k*AICBICRushton model$2.25 \times 10^{3}$0.9930.9934.3511.994.78Linear outer diameter model$1.07 \times 10^{4}$0.9650.9659.4811.964.75Polynomial expansion (full)29.80.99990.99980.521020.0047.87Polynomial expansion (cross-terms only)$1.43 \times 10^{3}$0.9950.9953.4936.0014.36Table 3Acquisition parameters used for simulations of diffusion and relaxometry MRI data and for *in vivo* data acquisition.Table 3ParameterValue**Diffusion acquisitions**Flip angle$90^{o}$Slice thickness2 mmField of View$220 \times 220$ mmMatrix size$110 \times 110$Voxel size$2 \times 2 \times 2$ mmCHARMED*b*\[500,1200,2400,4000,6000\] $\text{s}\text{mm}^{- 2}$\# directions\[30,60,60,60,60\]*δ*7 ms$\text{Δ}$23.3 msEcho time48 msRepetition time2600 msAxCaliber$G_{max}$290 $\text{mT}\ \text{m}^{- 1}$*b*optimised to achieve 100% and 50% of $G_{max}$\# directions\[30,60\]*δ*7 ms$\text{Δ}$\[17.3,30,42,55\] msEcho time80 msRepetition time3900 ms**Relaxometry acquisitions**Slice thickness1.72 mmField of View$220 \times 220$ mmMatrix size$128 \times 128$Voxel size$1.72 \times 1.72 \times 1.72$SPGRFlip angles\[3,4,5,6,7.5,9,12,15,18\] ^*o*^Echo time1.9 msRepetition time4.2 msIR-SPGRFlip angle5°Echo time1.9 msRepetition time4.2 msInversion Time450 msSSFPFlip angles\[10,10,15,15,20,20,30,30,40,40,50,50,60,60\] ^*o*^Phase cycle angles\[0,180,90,270,0,180,90,270,0,180,90,270,0,180,90,270\] ^*o*^Echo time2.27 msRepetition time4.54 msSlice thickness1.72 mm

With the exception of geometric interdependencies, all parameters were assumed to be independent, with two exceptions (1) the relationship between the node diameter and inter-node axon diameter. and (2) the relationship between axon diameter and the inter-nodal length (INL) [@bib38]; [@bib80]; [@bib53]; [@bib33]; [@bib69]; [@bib40]. Since these relationships are well established in the literature, reproducing these relationships in the simulations will ensure greater ecological validity.

The nodal axon diameter was modelled as a linear function of the (inter-nodal) axon diameter:$$\phi_{ND} = \alpha_{ND}d + \beta_{ND}$$

The INL was modelled as a log relationship with the outer fibre diameter.$$\phi_{INL} = \alpha_{INL}\ \log\left( {\frac{d}{g} + \gamma_{INL}} \right) + \beta_{INL}$$

The coefficients $\alpha_{i}$, $\beta_{i}$ $\gamma_{i}$ were optimised to fit a simulated joint distribution of ADs and g-ratios ($n = 1000$, mean and s.d. matched those listed in [Table 1](#tbl1){ref-type="table"}) such that the mean and s.d. of the node diameter and INL also match those listed in [Table 1](#tbl1){ref-type="table"}. The coefficients obtained for node diameter were $\alpha_{ND} = 0.63,\beta_{ND} = 0.21$ and for INL were $\alpha_{INL} = 159.16,\beta_{INL} = 153.74,\gamma_{INL} = - 0.227$. In the simulations, each model axon was subjected to a current stimulation applied for 10 ​s to the first node. The amount of current was calibrated such that it produced a peak membrane depolarisation of +50 ​mV in the first node (in the baseline condition, this results in a stimulus amplitude of 2.73 ​nA). The resultant CV was then obtained over a 10-node interval between the 30th and 40th node, except in cases where the CV was too slow for action potentials to reach the 40th node in the simulation duration, in which case the recording interval was moved to earlier segments so that CVs could be obtained. To establish that action potentials propagated consistently along the length of the axon, simulations were checked to ensure membrane potential peaks of at least −40 mV were achieved on a minimum of 10 consecutive nodes.

### 2.1.2. Sensitivity analysis {#sec2.1.2}

Sensitivity was assessed by sampling the corners of a 14-dimensional hypercube in the parameter space, i.e., for every possible combination of positive and negatives changes in each parameter, the CV was simulated and the difference computed, along that dimension of the hypercube. The dimensions of the hypercube were set to 1 s.d. around the baseline condition (with baseline being the same conditions used for the simulations in [@bib6], given in [Table 1](#tbl1){ref-type="table"}), where s.d. was determined from experimental observations in optic nerve ([@bib6]; [@bib12]), or 20% where no such data were available. An exhaustive analysis of $2^{14} = 16,384$ comparisons were made. All simulations ran generated action potentials that propagated along the length of the axon.

An OAAT sensitivity analysis was performed for each parameter at 10 equally-spaced intervals within a 20% range around the baseline condition (see [Appendix B](#appsec2){ref-type="sec"}). This shows that relative changes in CV are approximately linear with change in parameter so we can assume that sampling only the corners of the hypercube is sufficient to capture the variability in CV within this region of the parameter space. The change in CV, $\text{Δ}v\left( \text{Φ} \right) = v\left( \text{Φ} \right)^{+} - v\left( \text{Φ} \right)^{-}$, for a given set of parameters $\text{Φ}$, due to a change in each individual parameter $\text{Δ}\phi_{i} = \phi_{i}^{+} - \phi_{i}^{-}$, relative to the CV of the baseline condition $v\left( {\text{Φ}'} \right)$ was calculated. This resulted in $2^{14 - 1} = 8,162$ relative changes. The proportional variance was computed by taking the sum of these changes and normalising to the total variance. The corresponding sensitivity was calculated by normalising the relative change in CV to the relative change in the parameter.$$S\left( \phi_{i} \right) = \frac{\text{Δ}v\left( \text{Φ} \right)/v\left( {\text{Φ}'} \right)}{\text{Δ}\phi_{i}/\phi'_{i}}$$

### 2.1.3. Testing simplified models of CV {#sec2.1.3}

We aimed to derive a simple model to predict CV (and associated variance) from the two parameters that have previously been reported as accessible from *in vivo* MRI: g-ratio, and AD. We tested the model across a grid comprising 10 approximately equally-spaced AD values (0.5--12.5 $\text{μm}$) and 12 equally-spaced values of *g* (0.4--0.95). For each grid-point, we repeated the hypercube sensitivity analysis by running the Model C ([@bib61]) simulation across all possible combinations of the remaining non-MRI accessible parameters, to generate a distribution of CVs for each point on the grid. This resulted in $10 \times 12 \times 2^{12} = 491,520$ model runs. The mean and s.d. of CV at each point was calculated. We then fitted simplified models based on the Rushton formula ([@bib63]) and the linear relationship with outer diameter ([@bib83]) to the mean CV values. We also explored some more complex polynomial models that could potentially provide better fits to the data. In all cases, metrics of the model fit performance and parsimony, including [@bib3] and Bayesian ([@bib65]) information criteria (AIC and BIC) were computed, using the likelihood values computed from $\ln\widehat{L} = \left( {1 - R^{2}} \right)/2$.

2.2. Results {#sec2.2}
------------

The conduction velocity obtained in the baseline condition was 2.95$\text{ms}^{- 1}$, in agreement with the original simulations in [@bib6] (see also [Appendix A](#appsec1){ref-type="sec"} for further validation). Action potential propagation was successful in all simulations. The distribution of relative changes in CV, due to change in each parameter, is shown in [Fig. 1](#fig1){ref-type="fig"}(a), while [Fig. 1](#fig1){ref-type="fig"}(b) shows the total variances in CV due to change in each parameter relative to the total variance. The majority of the variance is explained by AD, followed by myelin periodicity, g-ratio and internodal length. A key finding of this analysis is that combined together, AD and g-ratio explain 85.1% of the model variance in CV. The distribution of relative sensitivities of CV to unit changes in each parameter are shown in [Fig. 2](#fig2){ref-type="fig"}(a) while [Fig. 2](#fig2){ref-type="fig"}(b) shows the sum-squared sensitivity for each parameter, proportional to the sum-squared sensitivity across all parameters. CV is most sensitive to a unit change in g-ratio by a considerable margin. AD has the second highest sensitivity. Combined together, AD and g-ratio account for 94.6% of the total sensitivity of CV.Fig. 1(a) Distributions of relative change in CV for a stepwise change in each parameter (parameter step size determined by limits indicated in [Table 1](#tbl1){ref-type="table"}) across all points tested in the parameter space (8,162). (b) The total variance for each parameter step change as proportion of variance across all simulations. MRI-visible parameters indicated by green bars.Fig. 1Fig. 2(a) Distributions of relative sensitivities of CV to unit change in each parameter across all points in the parameter space (8,162). (b) The sum-squared relative sensitivity for each parameter step change as proportion of the total sum-squared sensitivity across all simulations. MRI-visible parameters indicated by green bars.Fig. 2

The distribution of CVs across AD and g-ratio are shown in [Fig. 3](#fig3){ref-type="fig"}. The mapping of CV to AD appears approximately linear, while the mapping to *g* follows an inverse log square root function. This is similar to the form given in the Rushton formula. ([@bib63]).$$v = pd\sqrt{- \text{log}\left( g \right)}$$where *p* is some constant of proportionality, which we estimated in our data to be $p = 16.99$ (confidence bounds: $\left\lbrack 16.8,17.2 \right\rbrack$). The 2D fitting to the original Rushton model yielded a good fit (sum squared error (SSE) = $2.247 \times 10^{3}$, $R^{2} = 0.993$), but the fit was poor where AD is large and g-ratio is small ([Fig. 4](#fig4){ref-type="fig"}).Fig. 3Distribution of CV estimates for each fixed values of AD and g-ratio, across the remaining 12 parameter ranges. Surface plot indicates the mean value. Black dots show the distribution of CV estimates at each point.Fig. 3Fig. 4Plots of simplified models fitted to simulated data points across AD and g-ratio values (mean for each AD-g pair indicated by red circles). (a) Rushton model as fitted across values of AD and *g*; (b) Rushton model as a linear fit to $d\sqrt{- log\left( g \right)}$; (c) outer diameter model as fitted across values of *d* and *g*; (d) outer diameter model as a linear fit to outer diameter ($d/g$); (e) Full 3rd order polynomial expansion in *d* and $\sqrt{- log\left( g \right)}$; (f) the same polynomial expansion only considering the cross-terms.Fig. 4

We also tested whether CV could be predicted from a linear function of outer diameter ([@bib83]). This is simpler to calculate since it uses only one parameter but implicitly assumes a constant *g*-ratio.$$v = p\frac{d}{g}$$where *p* was estimated from our data to be $p = 6.67$ (confidence bounds: $\left. \left\lbrack 6.50,6.85 \right\rbrack \right)$. Note, the goodness of fit was slightly poorer for this model compared to the Rushton model (SSE = $1.07 \times 10^{4}$, $R^{2} = 0.964$). The AIC and BIC were comparable to the Rushton model.

Further comparison was made between the two models by computing the SSE for each AD-g pair and plotting the difference in SSE ([Fig. 5](#fig5){ref-type="fig"}). This shows that where AD is high (above $8\ \text{μm}$), there is a better fit (lower SSE) for the Rushton model where g-ratio lies between 0.5 and 0.75. The outer diameter model shows better fit where g-ratio lies between 0.75 and 0.95. Below ADs of $8\ \text{μm}$, there is little difference between the two models.Fig. 5Difference in SSE between the Rushton and linear outer-diameter models. Positive values (green) show higher SSE for The Rushton model, negative values (red) show higher SSE for the outer diameter model.Fig. 5

Two more complex models were tested to compare with the Rushton and linear outer diameter models. A 3rd order 2D polynomial expression in *d* and $\sqrt{- \text{log}\left( g \right)}$ yielded a better fit (SSE = 29.8$R^{2} = 0.9999$) but required fitting of 10 coefficients. A good fit was also achieved when considering only cross-terms in the same polynomial, (SSE = $1.43 \times 10^{3}$$R^{2} = 0.995$) which only requires 3 coefficients.$$v = p_{11}d\sqrt{- \text{log}\left( g \right)} + p_{21}d^{2}\sqrt{- \text{log}\left( g \right)} - p_{12}d\ \log\left( g \right)$$

However, the AIC and BIC are lowest for the Rushton model. Therefore, this remains the preferred model for predicting CV ([Fig. 4](#fig4){ref-type="fig"}). The s.d. of the modelled CVs scaled linearly with the mean CV (coefficient = 0.350, SSE = 945.9, $R^{2} = 0.977$).

3. Estimating CV from MRI-derived parameters {#sec3}
============================================

The second part of this study focuses on the second issue highlighted in the introduction: Is it possible to obtain accurate CV estimates from parameters derived from existing microstructural MRI techniques?

From diffusion MRI, there exist several models for estimating axonal density (e.g. CHARMED ([@bib7]) or NODDI ([@bib87])) and axon diameter (AxCaliber ([@bib8]) and ActiveAx ([@bib4])). Similarly, myelination can be estimated from relaxometry ([@bib25]) and magnetisation transfer imaging ([@bib68]; [@bib85]). Combining estimates of axonal and myelin volume fraction allows the generation of *in vivo* maps of g-ratio, for example, by combining, NODDI and qMT ([@bib72]), NODDI and mcDESPOT ([@bib21]) or CHARMED and MTV ([@bib28]). A recent review of MRI based g-ratio estimation is provided by [@bib16].

All these techniques work by fitting microstructural parameters to biophysical models of the MRI signal using some numerical optimisation routine. This approach has some inherent issues. MRI signals are subject to noise from a range of sources. There are problems with fitting model parameters to MRI signals, including degeneracy of solutions in the optimisation process, and the likelihood of fitting the model to noise contributions. As a result, there can be considerable bias in MRI-derived microstructural metrics ([@bib44]). We note, in particular, that quantification of inner AD is challenging, if not impossible, at gradient strengths found on typical clinical MRI system (up to 80 mT/m) ([@bib14]; [@bib49]; [@bib54]; [@bib79]). This was a criticism levied at the study of Horowitz et al. ([@bib42]; [@bib49]). However, the advent of ultra strong gradient systems (300 mT/m) provides sensitivity to AD, at least over a limited but relevant range (i.e. above $3\ \text{μm}$) ([@bib54]). In this work we therefore focus on simulation (and real data) on an ultra strong gradient system. Although this is a special case, it does allow us to evaluate the feasibility of estimating CV *in vivo*.

This issue of model bias can become even more pernicious if some models take as input the output of other models, leading to propagation of noise and bias through different models. It is imperative, therefore, that MRI-derived estimates of CV are robust to such errors, which is the subject of investigation in the present study.

3.1. Method {#sec3.1}
-----------

To model the effects of MRI noise, MRI data were simulated using analytical expressions for three biophysical models, the Composite Hindered and Restricted Model of Diffusion (CHARMED) ([@bib7]), the AxCaliber model ([@bib8]) and multicomponent driven equilibrium single pulse observation of T1/T2 (mcDESPOT) relaxometry ([@bib25]).

3.2. Core biophysical simulations {#sec3.2}
---------------------------------

A single population of axons whos AD distribution is parametrised by a continuous Poisson distribution (mean and s.d. of ADs is parameterised by *λ*) was simulated. The simulations assume no orientational dispersion or crossing fibre configuration. The biophysical parameters of the system are listed in [Table 4](#tbl4){ref-type="table"}. Systems with this configuration were simulated for a range of AVFs, axon diameters and g-ratios. The g-ratio value is treated as an aggregate estimate of g-ratio across the volume. 6 AVF values were tested from 0.1 to 0.7; 12 approximately evenly-spaced mean AD values from 0.5 to 12.5 $\text{μm}$ and 11 evenly-spaced g-ratio values of 0.4--0.9.Table 4Fixed biophysical parameters used for the MRI simulations.Table 4Fixed biophysical parametersParameterUnitsValueIntracellular axial diffusivity$\text{cm}^{2}\ \text{s}^{- 1}$2.0Extracellular axial diffusivity$\text{cm}^{2}\ \text{s}^{- 1}$1.3Extracellular radial diffusivity$\text{cm}^{2}\ \text{s}^{- 1}$0.15Orientation (*θ*)rad$\pi/2$Orientation (*ϕ*)rad0Myelin $T_{1}$ms0465Myelin $T_{2}$ms26Myelin residence timems180Extracellular $T_{1}$ms1070Extracellular $T_{2}$ms50CSF $T_{1}$ms4000CSF $T_{2}$ms2500CSF volume fraction0.05

### 3.2.1. Diffusion MRI simulation {#sec3.2.1}

Diffusion MRI data were simulated using the AxCaliber model, utilising a population of van Geldren cylinder models ([@bib78]) with a continuous Poisson distribution of ADs. The extracellular space was modelled as a zeppelin-shaped (cylindrically-symmetric) tensor. CHARMED and AxCaliber MRI data were simulated using the Microstructural Diffusion Toolbox (MDT) ([@bib36]) using parameters that matched a standard protocol used on a Siemens 300 mT/s Connectom system ([@bib45]) where a range of b-values and diffusion times were sampled ([Table 3](#tbl3){ref-type="table"}). The CHARMED and AxCaliber model were then fitted to the simulated data using the Powell optimisation routine ([@bib59]) using the MDT toolbox.

### 3.2.2. Relaxometry MRI simulation {#sec3.2.2}

mcDESPOT MRI data were simulated using the Quantitative Imaging Toolbox (QUIT) ([@bib86]). The protocol comprised 8 spoiled gradient recalled (SPGR) images with varying flip angles and 16 steady-state free precession (SSFP) ([Table 3](#tbl3){ref-type="table"}) images distributed across 8 flip angles and 4 phase cycle angles. To account for the influence of radio frequency field strength ($B_{1}$) and off-resonance frequency ($F_{0}$) in the fitting, a range of $B_{1}$ and $F_{0}$ values were simulated for each noise measurement. To replicate the noise profile obtained from SNR measurements across flip angles, noiseless data were simulated and Rician noise with flip-angle-specific s.d. was added to the simulated data (see [Appendix C](#appsec3){ref-type="sec"}). A 3-pool model (modelling contributions from myelin, extra-cellular and CSF water) was then fitted to the simulated data using the 'qimcdespot' function in the QUIT toolbox.

Since mcDESPOT gives a myelin water fraction (MWF) map, as opposed to a true MVF, we estimated the true MVF from the formula:$$\text{MVF} = \frac{\text{MWF}\left( {1 + \omega} \right)}{1 + \omega\text{MWF}}$$where $\omega = 0.72$ is the ratio of lipid to water in the myelin ([@bib2]) (see [Appendix D](#appsec4){ref-type="sec"} for derivation). Similarly the axonal water fraction (AWF) obtained from the CHARMED model is not a true AVF. This can be obtained from:$$\text{AVF} = \left( {1 - \text{MVF}} \right) \times \text{AWF}$$

### 3.2.3. g-ratio and CV estimation {#sec3.2.3}

g-ratios were computed using the approach of [@bib72]:$$g = \frac{1}{\sqrt{1 + \frac{\text{MVF}}{\text{AVF}}}}$$

This approach has been shown to give a valid aggregate measure of g-ratio for a distribution of ADs. Using the Rushton model (Eq. [(4)](#fd4){ref-type="disp-formula"}), with $p = 16.99$ as fitted previously using simulations, CV was estimated for each combination of mean AD and g-ratio.

### 3.2.4. Noise {#sec3.2.4}

Noise was simulated by adding Rician noise to each simulated MRI acquisition. The s.d. for each acquisition was modified to replicate the SNR profiles observed in real data (see [Appendix C](#appsec3){ref-type="sec"}). Additionally, to test sensitivity to noise, data simulations were repeated with noise s.d. at 50% and 200% of the original noise s.d. This was done for all permutations across the 3 MRI parameters. For all simulated acquisition and permutations of noise levels, 100 iterations were performed. This resulted in a total of $100 \times 3 \times 6 \times 10 \times 11 = 198,000$ diffusion MRI simulations and $100 \times 3 \times 6 \times 11 = 19,800$ relaxometry MRI simulations.

### 3.2.5. Error measurements {#sec3.2.5}

Errors in CV estimates were quantified in the following ways:1.Bias was quantified by the mean relative error in CV. The same was also done for the derived biophysical parameters required to compute CV (AVF, MVF, g and AD).2.Variance was quantified by the variance of the CV estimates normalised to the original CV estimate.3.Relative sensitivity to errors in parameter estimates was derived analytically, since the expression for CV is agnostic to the method used to estimate MWF and AWF and is easy to differentiate with respect to the initial fitted parameters (AD, MWF and AWF) by substituting equation [(8)](#fd8){ref-type="disp-formula"} 7 9 into equation [(4)](#fd4){ref-type="disp-formula"}. The calculation of relative sensitivity is adapted from eq. [(3)](#fd3){ref-type="disp-formula"} for analytical derivatives:$$S\left( \phi_{i} \right) = \frac{\partial v}{\partial\phi_{i}}\left( {\text{Φ}'} \right)\left| \frac{\phi'_{i}}{v\left( {\text{Φ}'} \right)} \right|$$4.Sensitivity to noise was estimated using eq. [(3)](#fd3){ref-type="disp-formula"} by taking the difference in CV estimates from simulations performed with 50% and 200% of the original noise level and normalising to the difference in noise s.d.

3.3. Results {#sec3.3}
------------

### 3.3.1. Errors in modelled parameters {#sec3.3.1}

Errors in relevant fitted parameters are shown in [Fig. 6](#fig6){ref-type="fig"} and distributions of errors across parameters are shown in [Fig. 7](#fig7){ref-type="fig"}. Overall, of the initially derived variables, the lowest errors are in the derived AWF (mean $\pm$ s.e.: $0.073 \pm 0.0003$) with highest errors for AD ($0.84 \pm 0.0029$). MWF errors are $0.21 \pm 0.0009$. Interestingly, errors in the derived g-ratios are lower than for its dependencies ($0.054 \pm 0.0001$). AWF and AVF have highest errors where g-ratio approaches infeasible values. AD values show the greatest errors where AD is low and AVF is low (i.e. where there is small contribution from intracellular diffusivity). There is a consistent positive bias in AD estimates, of up to 4 μm across all values of AD tested. Errors in g-ratio estimates are mostly uniformly low, but slightly higher errors where g-ratio is high and AVF is low. This corresponds to higher errors in the MWF/MVF estimates for these parameter values (where signal contributions from myelin water will be very small). g-ratio estimates are shown to have an increasing negative bias as g-ratio increases.Fig. 6(a) Log relative errors in AWF, AVF, MWF, MVF and g-ratio across ranges of g-ratio and AVF. (b) log relative errors in AD, across ranges of AD, g-ratio and AVF. (c) true vs estimated values for all estimated variables.Fig. 6Fig. 7Distributions of log relative errors in derived parameters AWF (dark blue), AVF (light blue), MWF (dark green), MVF (light green), g-ratio (orange) and AD (red) across all parameters.Fig. 7

### 3.3.2. Errors in CV estimates {#sec3.3.2}

Relative errors in CV across the parameter space tested are shown in [Fig. 8](#fig8){ref-type="fig"}. The CV estimates show a less than 5% bias across a region of parameter space where AVF is 0.3 or above and AD is above $4\ \text{μm}$. This boundary decreases slightly for AVF values of 0.4--0.6. There is little dependency on g-ratio except for very low AVF. Bias is greatest (over 50%) in regions where AVF is low (below 0.3) and AD is below 4$\text{μm}$. Examining the true vs estimated values show that there is generally a positive bias to CV estimates, of up to 50 $\text{ms}^{- 1}$, with some negative estimates where true CV is between 0 and 150 $\text{ms}^{- 1}$.Fig. 8(a) Log relative error in CV estimates across values of AVF, AD and g-ratio. (b) Regions of parameter space where relative variance is less than 5% (blue), 5--10% (green), 10--20% (yellow), 20--50% (orange) and greater than 50% (red) error in CV estimates. Black regions are where axon AVF/g-ratio combinations gives an infeasible MVF values.Fig. 8

### 3.3.3. Variance in CV estimates {#sec3.3.3}

Variance in CV estimates is shown in [Fig. 9](#fig9){ref-type="fig"}. The normalised variance is mostly below 0.5 where AVF is above 0.1 and AD is higher than 4 $\text{μm}$.Fig. 9(a) Log normalised variance in CV estimates across values of AVF, AD and g-ratio. (b) Regions of parameter space where normalised variance is less than 0.5 (coloured in blue) or greater than 0.5 (coloured in red).Fig. 9

### 3.3.4. Sensitivity to parameter errors {#sec3.3.4}

The relative sensitivity to AD is easy to derive, since the Rushton expression is a linear function of AD, so relative sensitivity is 1 across the whole parameter space.$$S\left( d \right) = 1$$

The relative sensitivities to AWF and MWF are more complex as CV are is not a simple linear function of AWF or MWF. Both sensitivities have dependencies on MWF and AWF, but not AD.$$S\left( \text{AWF} \right) = - \frac{\text{MVF}}{2\text{AVF}\left( {\frac{\text{MVF}}{\text{AVF}} + 1} \right)\text{log}\left( {\frac{\text{MVF}}{\text{AVF}} + 1} \right)}$$$$S\left( \text{MWF} \right) = \frac{\text{MVF}\left( {\frac{\text{MVF} - \omega\text{MVF}^{2}}{\text{AVF}} - \frac{\omega\text{MWF}}{\omega\text{MWF} + 1} + 1} \right)}{2\text{AVF}^{2}\left( {\frac{\text{MVF}}{\text{AVF}} + 1} \right)\text{log}\left( {\frac{\text{MVF}}{\text{AVF}} + 1} \right)}$$

The relative sensitivities evaluated for the AVF and g-ratio values used in simulations are shown in [Fig. 10](#fig10){ref-type="fig"}. Relative sensitivity to AD errors is the highest with a uniform value of 1. Errors in AWF have the smallest effect giving a small negative bias in CV ($- 0.14 \pm 0.030$). Errors in MWF give a moderate positive bias ($0.38 \pm 0.088$).Fig. 10(a) Relative sensitivity (derived analytically) of CV estimate to errors in AWF, MWF and AD. (b) Distribution of relative sensitivities across the parameter space tested.Fig. 10

### 3.3.5. Sensitivity to noise {#sec3.3.5}

Distributions of relative sensitivities to noise across the tested parameter space are shown in [Fig. 11](#fig11){ref-type="fig"}. Proportional variances are quite uniform across the parameter space. The proportional variance in CV estimates explained by noise across three MRI parameters are shown in [Fig. 12](#fig12){ref-type="fig"}, which is also mostly uniform across the parameter space tested. CV has the highest relative sensitivity to noise in AD estimates ($0.87 \pm 0.097$). CV has the lowest relative sensitivity to MWF estimates ($0.0031 \pm 0.0043$). Relative senstivity of CV to noise in AWF estimates was also low ($0.13 \pm 0.095$).Fig. 11Distributions of log relative sensitivity of CV to noise in AWF (blue), AD (red) and MWF (green) acquisitions across all parameters.Fig. 11Fig. 12Proportional variance explained by noise in MRI acquisition, across the parameter space tested.Fig. 12

3.4. *In vivo* CV estimates from human MRI data {#sec3.4}
-----------------------------------------------

As a proof of principle we apply the proposed approach to *in vivo* human data, subject to the caveats regarding the sensitivity to AD. Data were acquired on a high gradient MRI system. The analysis focuses on the corpus callosum as the axons here have a relatively uniform orientation and minimal dispersion.

3.5. Method {#sec3.5}
-----------

### 3.5.1. MRI acquisition {#sec3.5.1}

CHARMED, AxCaliber and mcDESPOT data were all acquired from 21 healthy human participants (2M, 19F; $25.7 \pm 9.9$ years of age) on a Siemens 3T 300 mT/m Connectom system (Siemens Healthcare, Erlangen, Germany). The acquisition parameters used were identical to those used in the simulations (see [Table 3](#tbl3){ref-type="table"}).

### 3.5.2. Diffusion MRI processing {#sec3.5.2}

Motion, eddy current and EPI distortions were corrected using FSL TOPUP and EDDY tools ([@bib5]). Correction for gradient non-linearities, ([@bib35]; [@bib62]), signal drift ([@bib81]) and Gibbs ringing artefacts ([@bib47]) was also performed. All diffusion data were then registered to a skull-stripped ([@bib71]) structural T1-weighted image using EPIREG ([@bib5]). AVF and AD parameters were fitted to the CHARMED and AxCaliber models using the MDT toolbox ([@bib36]) using the same optimisation routine used in the simulations.

### 3.5.3. Relaxometry MRI processing {#sec3.5.3}

Motion correction was applied to the SPGR and SSFP data using FSL mcFLIRT and then the brain was skull-stripped ([@bib71]). All subsequent fitting steps were performed using the QUIT toolbox ([@bib86]). A $B_{1}$ map was estimated by fitting the data to the DESPOT1-HIFI model ([@bib24]) and then fitting to a 8th order 3D polynomial. An $F_{0}$ map was estimated by fitting to the DESPOT2-FM model ([@bib23]). These were then used for the final fitting to the mcDESPOT model, as described for the MRI simulations. The final MVF maps were registered to the T1-weighted image using FLIRT ([@bib5]) so that all parameter maps were in the same image space.

### 3.5.4. Corpus callosum ROI {#sec3.5.4}

The corpus callosum was automatically segmented from the mid-sagital slice and divided into splenium, body and genu segments. The corpus callosum mask was eroded slightly with a disk kernel of radius 1.5 mm to minimise contributions from partial volume effects on the edge of the corpus callosum.

### 3.5.5. CV mapping {#sec3.5.5}

AVF, MVF, g-ratio and CV parameters were computed from the modelled AWF, MWF and AD parameters, in the same way used in the simulations. In an attempt to overcome the bias of AD estimation, we used the simulation results to generate a spline-interpolated mapping between the biased and unbiased AD estimates, and used this to make a bias-corrected AD map and a subsequent bias-corrected CV map.

3.6. Results {#sec3.6}
------------

*In vivo* MRI data in the corpus callosum are shown in [Fig. 13](#fig13){ref-type="fig"}. CV mean $\pm$ s.e estimates across all subjects are $21.6 \pm 3.1\ \text{m}\ \text{s}^{- 1}$ in the genu, $22.4 \pm 2.5\ \text{m}\ \text{s}^{- 1}$ in the body and $22.6 \pm 2.8\ \text{m}\ \text{s}^{- 1}$ in the splenium. The bias corrected CV estimates are $8.3 \pm 2.7\ \text{m}\ \text{s}^{- 1}$ in the splenium, $9.9 \pm 2.2\ \text{m}\ \text{s}^{- 1}$ in the body and $9.4 \pm 2.1\ \text{m}\ \text{s}^{- 1}$ in the splenium.Fig. 13(a) Fitted *in vivo* MRI data (n = 21) to microstructural parameters in segments of the corpus callosum. Error bars show mean and s.e. in three main segments of the corpus callosum. Green show data for individual subjects, blue shows the group averaged data. (b) Fitted parameters in the corpus callosum in an individual subject.Fig. 13

There is a distinct profile of highest CV estimates in the body compared to the genu, which is consistent across most subjects. There are slightly higher mean values in the splenium compared to the genu. The bias-corrected CV estimates are overall lower than the uncorrected estimates, but still are slightly high compared those measured in electrophysiology in primates (median value of $7.4\ \text{m}\ \text{s}^{- 1}$) ([@bib74]) or estimated from primate histology ($5.4 - 8.9\ \text{m}\ \text{s}^{- 1}$) ([@bib15]).

4. Discussion {#sec4}
=============

This work has explored the feasibility of obtaining conduction velocity (CV) maps from *in vivo* human MRI, using a simplified model of axonal CV. Results from the axon simulations demonstrate that 85.1% of the variance in CV, and 94.6% of the sum-squared sensitivity of CV, can be attributed to variance in AD and g-ratio. Examining the proportional variances (using ecologically valid variances and covariances in parameters where possible), implicate AD as the most important parameter, while looking at sensitivity to a unit change in parameter, g-ratio is implicated as the most important. Therefore, considering the fact that AD varies much more in axon populations than g-ratio, capturing accurate estimates of AD is clearly more important than g-ratio for CV estimation.

The [@bib63] and outer diameter ([@bib83]) models for CV both provide a reliable estimate of CV from MRI-derived estimates of g-ratio and AD. In addition, we show that it is possible to account for uncertainty in CV estimates due to parameters not accessible *in vivo*. Thus, when reliable estimates of AD and g-ratio can be made, it is feasible to obtain estimates of axonal CVs *in vivo*. The match in the parsimony measures (AIC/BIC) for the Rushton model and outer-diameter model ([Table 2](#tbl2){ref-type="table"}) were comparable, with a slight improvement in SSE for the Rushton model. Indeed, [@bib15] used the outer-diameter model to good effect (see also [@bib49] for a discussion of the merits of the outer diameter model). Examining the regional difference in the SSE ([Fig. 5](#fig5){ref-type="fig"}) it is shown that for g-ratios in the range 0.5--0.75 the Rushton model performs slightly better. Performance is better for the outer diameter model for large g-ratios. Given that most axons conform to the former range of g-ratio ([@bib72]), the Rushton model is the preferred approach, and thus an estimate of both inner diameter and g-ratio is valuable for mapping CV. It should be noted this primarily affects larger axons. With smaller axons, the two models are comparable in performance.

More complex models of CV derived using a polynomial expansion gave better fits than the two simpler models, but the parsimony measures indicate that, due to the increased number of coefficients, these models could be over-fitting the data. [Fig. 4](#fig4){ref-type="fig"}, shows that the main improvement in the polynomial models is in regions where AD is high and g-ratio is low. However, such axon configurations are uncommon: large diameter axons are unlikely to have very thick myelin sheaths. Therefore, in practice, there is little value gained by employing these more complex models to estimate CV *in vivo*.

In terms of sensitivity to errors in parameter estimation, we investigated the effects of bias in MRI-derived parameters, the sensitivity of CV estimates to these errors, and the sensitivity to noise. Overall we show that in regions where mean AD is high, the errors in CV estimates are typically below 10% over a large region of the parameter space. The threshold below which AD causes large errors in CV (above 50%) varies with AVF: about $5\ \text{μm}$ for AVF of 0.1, about $3\ \text{μm}$ for AVF of 0.3--0.6. For human CNS, this is problematic since ADs in human CNS are typically below 1 $\text{μm}$ ([@bib1]; [@bib50]; [@bib15]; [@bib66]). This limits the potential relevancy of CV estimates to human *in vivo* data (see section below for further discussion). Interestingly, the range of g-ratios at which CV estimates are optimal shifts upward as AVF increases. The same effect can be seen for g-ratio errors in [Fig. 6](#fig6){ref-type="fig"}. CV estimates were least accurate when the AVF is very small (0.1 or below). This is to be expected as more sparse axon populations will generate less signal and reduce performance of model fitting. Sensitivity to errors in AVF and MWF are comparatively low. However, CV is most sensitive to errors in AD. This is as expected, since the Rushton model has the highest sensitivity to AD. This, emphasise further the challenge CV estimation faces from poor AD estimation. This sensitivity is uniform across the parameter space, indicating that accurate AD estimation is critical for CV estimates, regardless of specific axon configurations.

4.1. Challenges faced by AD estimation {#sec4.1}
--------------------------------------

The most problematic aspect of estimation of CV, highlighted here, is the estimation of AD from dMRI. Since AD accounts for the most variability in CV, this presents a challenge to estimating CV from *in vivo* MRI. This was a major issue with the study of [@bib37]. In the study of [@bib11], the issue was circumvented by using ADs sampled from distributions derived from existing histology ([@bib1]). Given that our electrophysiological simulations show AD account for the most variance in CV, one would need to be able to capture individual-specific estimates of AD, to properly estimate individual-specific CV. Although they observed a small difference in CV between older and younger subjects, the authors conclude that *in vivo* AD estimates are necessary since this effects how much g-ratio contributed to CV. Using external population-level histological estimates of AD in the CV calculations, neglects any possible individual differences in AD. Methodological issues around the estimation of axon diameters must therefore be addressed to ensure accurate CV estimation across the whole CNS. Our attempts to estimate CV in corpus callosum, although showing a similar profile observed in the literature ([@bib15]), still result in a small positive bias compared to literature values, even after attempts to correct this bias. AD estimates are higher than expected while g-ratio estimates are in the expected range, consistent with the findings from our simulations.

The apparent inter-axonal diffusion perpendicular to the axon (which is used to estimate AD) is orders of magnitude smaller than the apparent extra-axonal diffusion ([@bib14]; [@bib49]; [@bib79]). This is the main challenge to estimating smaller ADs, and requiring acquisitions at high *b* values to ensure a non-negligible contribution from the intra-axonal space ([@bib79]). On clinical MRI systems with gradients of up to 70 mT/m, this is problematic. On such systems, ADs below $6\ \text{μm}$ will not be detectable. However, on a high gradient system (300 mT/m), where high *b* values are achievable, this can be reduced to 2--3 $\text{μm}$ ([@bib27]; [@bib67]; [@bib54]). This is still not good enough given that the majority of axons in the brain are lower than 1 $\text{μm}$ ([@bib1]; [@bib50]; [@bib15]; [@bib66]) and so obtaining accurate estimates of axon diameter across the whole brain is not currently possible. In our in-vivo data we attempted to correct for this positive bias, by creating a simple mapping between the biased and unbiased ADs from our simulations. Although AD estimates were closer to expected values, they were still high. Furthermore, this mapping is ill-conditioned as any true sub-resolution ADs will be estimated at the limit (about $2.5\ \text{μm}$ in our *in vivo* data). Fortunately, some recent preliminary evidence suggests that, even if the majority of axons are below the resolution limit, there is still sufficient signal from the larger axons at the tail of the distribution to allow us to extrapolate the shape of the distribution below this limit, and hence derive a more accurate mean AD ([@bib26]; [@bib18]; [@bib22]). If proven to be reliable, this would represent significant progress to improving AD, and hence CV estimation *in vivo* and warrants further exploration. Furthermore, development of MRI hardware with even stronger gradients of 500 mT/m ([@bib10]) lends hope to the AD resolution limit can be pushed even further down. Nevertheless, we stress that [currently]{.ul} measuring AD remains challenging and we are not suggesting that it is possible to estimate CV everywhere within the brain ([@bib49]).

An alternative to estimating internal AD is the framework of [@bib56], [@bib55]; [@bib31]; [@bib14]; [@bib49] which allows characterisation of diffusion in the extra-axonal space in terms of the packing geometry of axons, which is dependent on the outer fibre diameter. This is appealing as this is closely correlated to CV, and only requires estimation of one microstructural parameter, instead of two, as used by the Rushton model. [@bib49] suggest that the apparent correlation between AD and CV observed by [@bib37] is due to contributions from the extra-axonal diffusion to the signal not being modelled correctly. However, it is still unclear how outer fibre diameter can be disentangled from other geometric properties of the extra-cellular space (e.g. packing density and packing randomness) within this framework. Also, as highlighted in the present study, the Rushton model is more accurate than the outer diameter model for estimating CV over a more common range of g-ratios. However, the merits of this modelling framework deserve to be explored further.

4.2. Other considerations for MRI methods {#sec4.2}
-----------------------------------------

The estimated CV is assumed to be a valid aggregate measure of CV for a population of axons. The mean AD is parameterised by *λ* of the Poisson distribution and the g-ratio calculation has been shown to be valid for a distribution of ADs ([@bib85]). However, it is unclear if the CV value obtained from aggregated AD and g-ratio values is a valid aggregate representation of a distribution of CVs. What represents the most optimal parameterisation of the AD distribution also remains an open question. A continuous Poisson distribution was chosen in this work as it has only one parameter that characterises both the mean and standard deviation, thereby reducing model complexity and improve optimisation. However, other distributions may offer better approximations of distributions observed in histology ([@bib66]).

An additional challenge that remains unexplored is the estimation of AD in other white matter pathways, where there are multiple regions of fibre crossing and dispersion. In the present study, these configurations were not considered. However, such configurations can be challenging for models that assume a single fibre geometry, such as AxCaliber. It is possible to model multiple fibre populations ([@bib9]), but this substantially increases the number of parameters to estimate. The issue of dispersion can potentially be resolved by including a dispersion term into the AxCaliber model as done in the NODDI model. The Convex optimisation modelling for microstructure informed tractography (COMMIT) framework ([@bib19]) can estimate microstructural properties along a tractogrpahy streamline, assuming the parameter does not vary along the length of the tract. This will allow estimation of distinct axon diameters for distinct fibre populations.

We also note that different combinations of methods can yield different levels of accuracy in CV estimates. There numerous combinations of methods for estimating AWF and MWF that could be used to generate g-ratio maps, all with different advantages and limitations ([@bib29]; [@bib16]). In addition, different methods for estimating AD such as ActiveAx ([@bib4]) and time-dependent AxCaliber ([@bib20]) expands the number of permutations of methods even further. Further work is necessary to assess which combination produces the best estimates, similar to that of [@bib29]. Previous work has shown there is an inherent bias in mcDESPOT ([@bib48]; [@bib84]). Our simulations also show ([Fig. 8](#fig8){ref-type="fig"}(c)) a negative bias in MWF estimates for higher MWF values. However, our sensitivity analysis also shows that CV estimates have low sensitivity to MWF errors. While this study explored the impact of MRI noise on CV estimates, there is a number of other sources of confounding variance, such as motion, eddy currents, field inhomogeneities and gradient non-linearities that could impact on CV estimates to differing degrees.

4.3. Considerations for electrophysiological simulations {#sec4.3}
--------------------------------------------------------

While efforts have been made to incorporate true biological variability in the sensitivity analysis by taking parameter ranges from the literature, where available, the simulations are currently restricted to a single axon population. Variability should be considered across axon populations, where, for example, it is known that AD varies considerably throughout the CNS ([@bib58]) as well as along single axons ([@bib77]). Similarly within-axon variation in g-ratio, internodal length and nodal diameter also exist ([@bib32]). However, it is important to keep in mind that at the spatial resolution of MRI, (e.g. $2 \times 2 \times 2\text{mm}^{3}$), we effectively average the axonal properties over thousands of axons and, as such, such variations will be averaged out to a certain extent. Cross-correlations between axon parameters should also be considered. In our simulations, we forced such correlations between internode and nodal AD, and between AD and internodal length, since such relationships are well documented in the literature ([@bib82]). However, other cross-correlations are likely to exist in nature but not simulated here.

Despite these possibilities for future improvements, our simulations produced a constant of proportionality between fibre diameter and CV of 6.67 $\text{m}\ \text{s}^{- 1}/\text{μm}$, which is only slightly above the range of 5.5--6.0 $\text{m}\ \text{s}^{- 1}/\text{μm}$ commonly reported in the literature ([@bib34]; [@bib38]; [@bib63]; [@bib70]; [@bib83]; [@bib75]). Looking further at [Fig. 4](#fig4){ref-type="fig"}(d), it looks like fitting only axons with diameters less than $5\ \text{μm}$ would result in a smaller constant of proportionality. We are therefore confident we have captured the inter-relationships between parameters reasonably well. We also note that the strong contribution of INL to CV would mean neglecting the AD-INL correlation would result in a significant underestimation of this constant.

A key assumption made here is that the results of the axon simulations, whose baseline parameters are based on rat optic nerve ([@bib6]), are generalisable to other white matter axons, and to other species. an entirely valid assumption. For example, membrane capacitance has recently been shown to be lower in human neurons compared to rat neurons ([@bib30]). Moreover, there is a theoretical optimal g-ratio for a given fibre diameter ([@bib70]). In the present sensitivity analysis, the range of g-ratios tested is in an interval where the relationship between CV and g-ratio is monotonic and approximately linear. However, for other fibre populations with different ranges of g-ratios where the relationship is non-monotonic, the sensitivities may differ substantially. A potential future research avenue is to repeat the sensitivity analysis on a range of axon populations to see which populations better lend themselves to modelling with MRI. However, obtaining all the morphological and electrophysiological parameters for multiple populations presents significant practical challenges.

It has been demonstrated that the relative thickness of the water and lipid layers in myelin vary with age ([@bib2]), and consequently the assumed constancy of *ω* used in Eq. [(7)](#fd7){ref-type="disp-formula"} may not be valid. This issue can potentially be resolved by combining multiple myelin-sensitive contrasts, e.g. by adding in quantitative magnetisation transfer (qMT) ([@bib68]). While qMT does not provide unique sensitivity to lipids, it does have sensitivity to protons bound to lipids and macromolecules. It may therefore be possible to exploit qMT and relaxometry methods together to better characterise the water-lipid ratio in myelin.

4.4. Conclusion {#sec4.4}
---------------

We have demonstrated the feasibility of estimating CV for ensembles of axons from their diameter and g-ratio, estimated from *in vivo* microstructural MRI, provided axon diameters are sufficiently large to be modelled accurately. Difficulties associated with estimating smaller axon diameters present the largest challenge to CV estimation across the whole CNS. However, potential solutions are in development which will greatly improve the accuracy of MRI-based CV estimation.

Appendix A. Validation of axon model {#appsec1}
====================================

To ensure the implementation of the "Model C" axon model ([@bib61]) produces results consistent with [@bib6], simulations were carried out with the baseline condition and some parameters varied as described in this paper. All other model parameters were the same as used in the main simulations except that the stimulus current was fixed at 3 nA, as done in [@bib6]. The baseline condition produced a CV of 2.95 $\text{m}\ \text{s}^{- 1}$, consistent with the results of [@bib6]. The results for other parameter variations are shown in [Table A1](#tbl1){ref-type="table"} which are also consistent with those reported in [@bib6].Table A.1Changes in CV due to changes of parameters previously reported in ([@bib6]).Table A.1Parameter changedValueRelative change from baselineCV ( $\text{m}\ \text{s}^{- 1}$)Relative change from baselineNode length (nm)0.5−0.512.53−0.142.21.163.020.02Fast Na ​+ ​conductance ($\text{mS}\text{cm}^{- 2}$)21−0.302.64−0.11Number of wraps^†^6−0.142.66−0.10[^1]

Appendix B. OAAT sensitivity analyses {#appsec2}
=====================================

A one-at-a-time (OAAT) sensitivity analysis was performed for each parameter at 10 equally-spaced intervals within a $\pm 20\text{\%}$ range around the baseline condition. Results are shown in [Figure B1](#fig1){ref-type="fig"}, which shows all sensitivity to all parameters is approximately linear over the interval tested. In the main analysis, three of a set of six interdependent geometric parameters were manipulated: axon diameter, g-ratio and myelin periodicity. Three other parameters depend directly on these parameters: number of myelin wraps, myelin width and outer fibre diameter. As the impact of variance in these parameters will vary depending on which combinations of these parameters are fixed, we repeated the OAAT analyses for different combinations of fixings. The results are shown in [Figure B2](#fig2){ref-type="fig"}. For most combinations, the sensitivity to each parameter shows a trend in the same direction regardless of which combination of other parameters are fixed. Notable exceptions are for the g-ratio where the direction of the sensitivity varies depending on which parameters are fixed. Sensitivity to g-ratio shows a negative trend when axon diameter and myelin periodicity or axon diameter and number of wraps are fixed. Sensitivity to g-ratio shows a positive non-linear trend when myelin periodicity and myelin width are fixed.Figure B.1Results of OAAT analysis of sensitivity of CV to each of the free parameters tested.Figure B.1Figure B.2Results of OAAT analysis for the 6 interdependent geometric parameters with different combinations of parameter fixings.2Figure B.2

Appendix C. SNR measurements {#appsec3}
============================

SNR for the diffusion sequences used for the AxCaliber and CHARMED acquisitions and the SPGR and SSFP acquisition used for mcDESPOT were measured by acquiring two image volumes: (1) a standard image volume (for diffusion sequences, only a $b = 0\ \text{s}\text{mm}^{- 2}$ image was used as the noise distribution is not expected to be affected by the level of diffusion weighting) with the standard flip angle (see [Table 3](#tbl3){ref-type="table"}); and (2) a noise image volume acquired with exactly the same parameters but with the flip angle set to 0, such that there is effectively no echo received by the receiver coil. The noise s.d. was computed from the signal magnitude of the noise volume. The results are shown in [Table C1](#tbl1){ref-type="table"}.Table C.1*In vivo* measurements of SNR and corresponding s.d. values for acquisition sequences used for estimating CV. S.D. values quoted for mcDESPOT scans are the effective noise added to recreate SNR measured *in vivo*.Table C.1SequenceFlip angle (^o^)SNRnoise s.d.CHARMED9026900.019AxCaliber9017760.024mcDESPOT - SPGR322460.1344.527010.087628050.0697.526700.064923940.0621218730.0561510440.068184950.098mcDESPOT - SSFP1010,1360.0101514,2560.0082017,6660.0082519,0900.0073019,6590.0074018,2690.0075014,2720.0086097760.010

Appendix D. Estimating volume fractions from water fractions {#appsec4}
============================================================

mcDESPOT gives a myelin volume fraction (MWF) that is the proportion of the total water volume that resides in the myelin layers.$$\text{MWF} = \frac{\text{MWV}}{W}$$whereas calculation of g-ratios requires the myelin volume fraction (MVF), which is the proportion of the total volume that is myelin (both water and lipid components):$$\text{MVF} = \frac{\text{MWV} + \text{MLV}}{V}$$where $\text{MWV}$ is the myelin water volume, $\text{MLV}$ is the myelin lipid volume, *W* is the total volume of water and *V* is the total volume. If we assume that the ratio of water and lipid in the myelin compartment, *ω*, is constant, we can also express the MLV as:$$\text{MLV} = \omega\text{MWV}$$the total volume is given by:$$V = \text{MWV} + \text{MLV} + \text{AWV} + \text{EWV}$$where $\text{AWV}$ and $\text{EWV}$ are the volumes of axonal and extracellular water, respectively. The total water is given by:$$W = \text{MWV} + \text{AWV} + \text{EWV}$$

Assuming the only non-water compartment is the myelin phospho-lipid layers and that the contribution of phospho-lipid membranes from other cell types is negligible, this can be expressed as:$$W = V - \text{MLV}$$

Substituting this into the expression for the MWF gives:$$\text{MWF} = \frac{\text{MWV}}{V - \text{MLV}} = \frac{\text{MWV}}{V - \omega\text{MWV}}$$

Collecting terms of MWV and rearranging gives:$$\text{MWV} = \frac{V\text{MWF}}{1 + \omega\text{MWF}}$$

We can get an equivalent expression for the MLV by multiplying through by *ω*$$\text{MLV} = \frac{V\text{MWF}}{\frac{1}{\omega} + \text{MWF}}$$

Substituting these into the expression for MVF gives:$$\text{MVF} = \frac{\text{MWF}}{1 + \omega\text{MWF}} + \frac{\text{MWF}}{\frac{1}{\omega} + \text{MWF}} = \frac{\text{MWF}\left( {1 + \omega} \right)}{1 + \omega\text{MWF}}$$

The value of *ω* was taken from [@bib2] where the width of the lipid bilayers was about 4.6 nm and the intra- and extracellular water layers were each 3.2 nm, giving a lipid-water ratio of $\omega = 4.6/\left( {3.2 + 3.2} \right) = 0.72$. The relationship between MWF and MVF is show in [Figure D1](#fig1){ref-type="fig"}. This approach is similar to that used by [@bib46] although *ω* is parameterised slightly differently. The relationship between MWF and MVF derived here is in close agreement with that study. One difference to note is we assume *ω* to have no dependence on the number of myelin wraps. We note, for cases where the inner diameter is orders of magnitude greater than the width of the laminae (e.g. $0.82\ \text{μm}$ vs 15.6 nm in our axon model) and there are sufficient number of wraps (above 5), which is the case for the vast majority of white-matter axons, this dependence can be assumed to be negligible.

The axonal volume fraction (AVF) can then be obtained from the axon water fraction (AWF) given by the CHARMED model (denoted here $\text{AWF}_{d}$). The AWF obtained from CHARMED excludes contributions from myelin water due to the short T2 of this compartment and excludes contribution from myelin lipid due to insensitivity to contributions from myelin macromolecules. We therefore used the estimated MVF computed previously to obtain the AVF.$$\text{AWF}_{d} = \frac{\text{AWV}}{\text{AWV} + \text{EWV}} = \frac{\text{AWV}}{V - \text{MWV} - \text{MLV}} = \frac{\text{AVF}}{1 - \text{MVF}}$$

The AVF can therefore be obtained from the MVF estimated from mcDESPOT and the AWF given by CHARMED:$$\text{AVF} = \left( {1 - \text{MVF}} \right) \times \text{AWF}_{d}$$Figure D.1Theoretical relationships between MWF and MVF according to Eq. [(7)](#fd7){ref-type="disp-formula"} (left). and between AWF and AVF according to Eq. [(8)](#fd8){ref-type="disp-formula"} (right).3Figure D.1
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[^1]: ^†^, Number of wraps, AD and g-ratio were fixed for this simulation. This is equivalent to setting myelin periodicity to 18.5 nm (a relative change from baseline of 0.19).
